Builders FirstSource, Inc. (BLDR)
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Investigation
05/12/2022
Resolution
06/13/2022
This is a confidential investigation of whether certain directors & officers of Intra-Cellular Therapies, Inc. (ITCI) breached their fiduciary duties to Intra-Cellular and its shareholders.
Intra-Cellular investors and shareholders are encouraged to contact the law firm below for additional information.
04/21/2022
Intra-Cellular Therapies, Inc. files its proxy materials with the SEC for its 2022 annual meeting to be held on Thursday, June 9, 2022.
See more on Factual TimelineWe have marked this investigation as closed.
The stockholders annual meeting took place.
On 06/13/2022 the company issued the following statement:
(a) On June 9, 2022, Intra-Cellular Therapies, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders. Of 94,301,718 shares of common stock outstanding and eligible to vote as of the record date of April 19, 2022, a quorum of 86,630,915 shares, or 91.87% of the eligible shares, was present or represented by proxy.
(b) The following actions were taken at such meeting:
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.